§ Funding Round
Series B funding round for BigHat Biosciences raising $75M in July 2022
Series B funding round for BigHat Biosciences raising $75M in July 2022
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Organization | — | |
Andreessen Horowitz | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
General Catalyst | — | — |
| Organization | — | |
Kleiner Perkins | — | — |
| Organization | — | |
| Organization | — | |
Section 32LEAD | Organization | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | philip tagari | |
| Organization | — | |
Bristol Myers Squibb | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$94M
Top Valuation
-
BigHat Biosciences raised $75M in a Series B round.
The round was announced on 07/01/22.
The round was led by Section 32.
